ARCHIVES

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

Surgeons Feel Cooperative Groups Discriminate Against Them, Ask For Better Deals From CCIRC

March 11, 1977

DCT Board Sends Message On Cutting Grants to Extend Paylines, Then Tries To Take It Back

March 2, 1984

NCI News: Biospecimen Banks Program for NCTN

November 22, 2013

Funding Opportunities

September 27, 2002

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

October 19, 2007